Johnson & Johnson’s mission is to make disease a thing of the past by transforming individual lives, and fundamentally change the way diseases are managed, interpreted, and prevented, through innovation. More than 30,000 employees worldwide work to develop and bring innovative, high-quality pharmaceutical products and services to patients and caregivers. In Norway, Johnson & Johnson provides patient treatments through clinical trials and commercialization of the company’s pharmaceuticals within the therapeutic areas of hematology, oncology, immunology, neuroscience, pulmonary arterial hypertension and infectious diseases. The main office is located in Lysaker, Oslo, with around 55 employees. https://www.janssen.com/norway/ |